Salvatore Provenzano
Fondazione IRCCS Istituto Nazionale dei Tumori(IT)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Tuberous Sclerosis Complex Research, Soft tissue tumor case studies, Vascular Tumors and Angiosarcomas, COVID-19 and healthcare impacts
Most-Cited Works
- → Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer(2020)182 cited
- → Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)(2019)114 cited
- → Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients(2013)104 cited
- → Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma(2017)85 cited
- → Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study(2022)80 cited
- → SELNET clinical practice guidelines for soft tissue sarcoma and GIST(2021)78 cited
- → Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database(2016)73 cited
- → Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour(2014)66 cited
- → A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)(2023)37 cited
- → Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour(2017)37 cited